Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 145,968 | 77,474 | 30,767 | 1,279 | 0 |
| Cost of Goods | 61,619 | 27,512 | 4,588 | 35 | 0 |
| Gross Profit | 84,349 | 49,962 | 26,179 | 1,244 | N/A |
| Operating Expenses | 295,662 | 234,411 | 221,325 | 172,194 | 96,925 |
| Operating Income | -210,694 | -183,937 | -194,558 | -170,915 | -96,925 |
| Interest Expense | 1,472 | 2,672 | 3,937 | 2,664 | 958 |
| Other Income | 7,417 | 7,769 | 1,011 | 436 | 292 |
| Pre-tax Income | -204,749 | -178,840 | -197,484 | -173,143 | -97,591 |
| Net Income Continuous | -204,749 | -178,840 | -197,484 | -173,143 | -97,591 |
| Net Income | $-204,749 | $-178,840 | $-197,484 | $-173,143 | $-97,591 |
| EPS Basic Total Ops | -2.50 | -2.44 | -3.65 | -4.56 | -2.95 |
| EPS Basic Continuous Ops | -2.50 | -2.44 | -3.65 | -4.57 | -2.95 |
| EPS Diluted Total Ops | -2.50 | -2.44 | -3.65 | -4.56 | -2.95 |
| EPS Diluted Continuous Ops | -2.50 | -2.44 | -3.65 | -4.57 | -2.95 |
| EPS Diluted Before Non-Recurring Items | -2.50 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-211,330 | $-184,946 | $-192,532 | $-168,853 | $-95,478 |